Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

sections
  • 2 of 2

Combining two oral, targeted treatments in metastatic melanoma that has spread to the brain leads to a response in almost half of patients, according to research being presented at the American Society of Clinical Oncology conference

Combining two oral, targeted treatments in metastatic melanoma that has spread to the brain could help overcome the limitations of existing local treatments, such as radiation and surgery

Source  Shutterstock.com